KRYS icon

Krystal Biotech

57 hedge funds and large institutions have $223M invested in Krystal Biotech in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+12
Holders Change %
+26.67%
% of All Funds
1.24%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
17
Increased
19
Reduced
16
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Bank of America
51
Bank of America
North Carolina
$188K +$182K +5,530 +2,973%
DMK
52
David M. Knott
$121K +$71.7K +2,184 +145%
KBC Group
53
KBC Group
Belgium
$108K +$11.5K +350 +12%
Morgan Stanley
54
Morgan Stanley
New York
$63K -$68.6K -2,085 -52%
CSS
55
Cubist Systematic Strategies
Connecticut
$16K +$16K +500 New
DWA
56
Dorsey Wright & Associates
California
$11K -$11K -342 -50%
Federated Hermes
57
Federated Hermes
Pennsylvania
$4K -$26.9K -834 -87%
Invesco
58
Invesco
Georgia
-$979K -47,113 Closed
MCM
59
Moore Capital Management
New York
-$260K -12,500 Closed
BFM
60
Boothbay Fund Management
New York
-$209K -10,038 Closed
TRCT
61
Tower Research Capital (TRC)
New York
-$24K -1,140 Closed
UBS Group
62
UBS Group
Switzerland
-$14K -675 Closed